Attenuated Mycobacterium tuberculosis vaccine protection in a low-dose murine challenge model-Reference-Cited by-同舟云学术

Attenuated Mycobacterium tuberculosis vaccine protection in a low-dose murine challenge model

Published:2023-06 Issue:6 Volume:26 Page:106963
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Vidal Samuel J.,Sellers Daniel,Yu Jingyou,Wakabayashi Shoko,Sixsmith Jaimie,Aid Malika,Barrett Julia,Stevens Sage F.,Liu Xiaowen,Li Wenjun,Plumlee Courtney R.,Urdahl Kevin B.,Martinot Amanda J.,Barouch Dan H.^ORCID

Funder

Musk Foundation

NIAID

Massachusetts Consortium on Pathogen Readiness

Bill and Melinda Gates Foundation

Ragon Institute of MGH, MIT and Harvard

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference33 articles.

1. Global Tuberculosis Report,2021

2. Variation in protection by BCG: implications of and for heterologous immunity;Fine;Lancet,1995

3. Moving tuberculosis vaccines from theory to practice;Andersen;Nat. Rev. Immunol.,2019

4. The End TB Strategy,2015

5. Protective efficacy of an attenuated Mtb ΔLprG vaccine in mice;Martinot;PLoS Pathog.,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Host and pathogen genetic diversity shape vaccine-mediated protection to Mycobacterium tuberculosis;Frontiers in Immunology;2024-06-28

2. Live Attenuated Vaccines against Tuberculosis: Targeting the Disruption of Genes Encoding the Secretory Proteins of Mycobacteria;Vaccines;2024-05-12

3. Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development;npj Vaccines;2024-03-09

4. Assessing vaccine-mediated protection in an ultra-low dose Mycobacterium tuberculosis murine model;PLOS Pathogens;2023-11-27

5. Assessing vaccine-mediated protection in an ultra-low doseMycobacterium tuberculosismurine model;2023-03-22